<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<meta content="dark" name="color-scheme"/>
<meta content="Expanded &amp; annotated works cited for pediatric pulmonary valve deep dive. Accessible, searchable, and printable single-file reference." name="description"/>
<title>Works Cited / References – Expanded &amp; Annotated</title>
<style>
    :root{
      --bg:#0b1220;--panel:#121a2b;--muted:#30415f;--card:#0f1626;--text:#ebf2ff;--accent:#4cc9f0;--accent-2:#a3ffb0;--warn:#ffd166;
      --shadow:0 10px 30px rgba(0,0,0,.25);
      --radius:16px;
    }
    *{box-sizing:border-box}
    html,body{height:100%}
    body{margin:0;background:linear-gradient(180deg,var(--bg),#0a0f1a);color:var(--text);font-family:Inter,ui-sans-serif,system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial;line-height:1.5}
    a{color:var(--accent);text-decoration:underline}
    a:hover{text-decoration:none}
    .skip-link{position:absolute;left:-9999px;top:auto;width:1px;height:1px;overflow:hidden}
    .skip-link:focus{position:fixed;left:16px;top:16px;width:auto;height:auto;background:#0a1324;border:2px solid var(--accent);border-radius:10px;padding:8px 12px;z-index:9999}

    .app{display:grid;grid-template-columns:280px 1fr;min-height:100vh}
    aside{background:var(--panel);padding:20px;border-right:1px solid #1f2b44}
    main{padding:28px 32px}
    .brand{display:flex;align-items:center;gap:12px;margin-bottom:16px}
    .logo{width:36px;height:36px;border-radius:10px;background:linear-gradient(135deg,var(--accent),#5ef0c4)}
    h1{font-size:22px;margin:0}
    .subtle{color:#b7c3d7;font-size:12px}
    nav ul{list-style:none;padding:0;margin:10px 0 0}
    nav li{margin:4px 0}
    .nav-link{display:flex;align-items:center;gap:10px;padding:10px 12px;border-radius:10px;color:#cfe3ff}
    .nav-link[aria-current="true"], .nav-link:hover{background:#0a1324}
    .chip{font-size:11px;padding:2px 8px;border:1px solid var(--muted);border-radius:999px;color:#a6b6d6}
    .section{scroll-margin-top:90px;margin-bottom:28px}
    .header{position:sticky;top:0;background:linear-gradient(180deg,rgba(11,18,32,.98),rgba(11,18,32,.85));backdrop-filter:blur(8px);z-index:20;padding:14px 24px;border-bottom:1px solid #17233a;display:flex;align-items:center;gap:14px}
    .header h2{margin:0;font-size:18px}
    .grid{display:grid;gap:16px}
    .grid.cols-2{grid-template-columns:repeat(2,minmax(0,1fr))}
    .grid.cols-3{grid-template-columns:repeat(3,minmax(0,1fr))}
    @media (max-width:1100px){.app{grid-template-columns:1fr}.grid.cols-2{grid-template-columns:1fr}.grid.cols-3{grid-template-columns:1fr 1fr}}
    @media (max-width:720px){.grid.cols-3{grid-template-columns:1fr}}
    .card{background:linear-gradient(180deg,var(--card),#0a0f1a);border:1px solid #1b2742;border-radius:var(--radius);padding:18px;box-shadow:var(--shadow)}
    .card h3{margin:0 0 6px;font-size:16px}
    .ref{margin:14px 0}
    .ref b{display:block;font-weight:600}
    .ref .small{font-size:12px;color:#9fb0cc}
    .pill{padding:4px 8px;border-radius:8px;background:#0e1b32;border:1px solid #22365b;color:#a6bee6}
    .btn{display:inline-flex;align-items:center;gap:10px;background:linear-gradient(180deg,#182844,#0e1a30);border:1px solid #213358;border-radius:12px;padding:8px 10px;color:#cfe3ff;cursor:pointer}
    .btn:hover{filter:brightness(1.1)}
    .btn.small{padding:4px 8px;border-radius:10px;font-size:12px}
    .sep{height:1px;background:#1a2743;margin:14px 0}
    .muted{color:#9fb0cc}
    .kbd{font-family:ui-monospace,Menlo,Monaco,Consolas,monospace;background:#0a1324;border:1px solid #1e2a44;border-bottom-width:2px;border-radius:8px;padding:2px 6px;color:#cfe3ff}
    .toolbar{margin-left:auto;display:flex;gap:10px;align-items:center}
    .search{display:flex;align-items:center;gap:8px}
    .search input{background:#0a1324;border:1px solid #1e2a44;border-radius:10px;padding:8px 10px;color:#cfe3ff;min-width:280px}
    .count{font-size:12px;color:#a6b6d6}

    .ref-actions{display:flex;gap:6px;margin-top:6px}

    :focus-visible{outline:2px solid var(--accent);outline-offset:2px}
    @media (prefers-reduced-motion: reduce){*{animation:none!important;transition:none!important}}

    /* Print-friendly */
    @media print{
      body{background:#fff;color:#000}
      .app{grid-template-columns:1fr}
      aside,.header .btn,.toolbar{display:none!important}
      a{color:#000;text-decoration:underline}
      a::after{content:" (" attr(href) ")";font-size:10px}
      .card{border-color:#000;box-shadow:none}
    }
  </style>
</head>
<body>
<a class="skip-link" href="#main">Skip to main content</a>
<div class="app">
<aside aria-label="Section navigation">
<div class="brand">
<div aria-hidden="true" class="logo"></div>
<div>
<h1>Works Cited</h1>
<div class="subtle">Expanded &amp; Annotated</div>
</div>
</div>
<nav aria-label="On‑page sections">
<ul>
<li><a class="nav-link" href="./index_linked.html" rel="prev">← Back to Index</a></li>
<li><a class="nav-link" href="./Consolidated_Deep_Dive_Dashboard_client_friendly.html" id="backDashLinkAside">← Back to Consolidated Dashboard</a></li>
<li class="sep" role="presentation"></li>
<li><span class="chip">Sections</span></li>
<li><a class="nav-link" href="#market">Market Sizing (Top‑Down &amp; Bottom‑Up)</a></li>
<li><a class="nav-link" href="#epi">Epidemiology &amp; Burden</a></li>
<li><a class="nav-link" href="#soc">Standard of Care &amp; Technologies</a></li>
<li><a class="nav-link" href="#reg">Regulatory &amp; Funding</a></li>
<li><a class="nav-link" href="#company">Company &amp; Pipeline</a></li>
<li><a class="nav-link" href="#comps">M&amp;A Comps &amp; Valuation</a></li>
<li><a class="nav-link" href="#guidelines">Guidelines &amp; Registries</a></li>
<li><a class="nav-link" href="#ip">Patents &amp; IP</a></li>
<li><a class="nav-link" href="#internal">Internal Osprey Materials</a></li>
</ul>
</nav>
</aside>
<main id="main">
<header class="header" role="banner">
<h2>Works Cited / References</h2>
<span class="pill">Public anchors + Osprey internal models • clearly labeled</span>
<div class="toolbar">
<div aria-label="Search references" class="search" role="search">
<label class="subtle" for="q">Search</label>
<input aria-describedby="resultCount" id="q" placeholder="Find citations, figures, or #tags (press / to focus)" type="search"/>
</div>
<button class="btn" id="clear">Clear</button>
<span aria-live="polite" class="count" id="resultCount"></span>
</div>
<a class="btn" href="./Consolidated_Deep_Dive_Dashboard_client_friendly.html" id="backDashLink">← Back to Dashboard</a>
</header>
<!-- Market Sizing -->
<section aria-labelledby="h-market" class="section" id="market">
<div class="card">
<h3 id="h-market">Market Sizing (Top‑Down &amp; Bottom‑Up)</h3><div class="ref"><b>Global Cardiovascular Devices – <span class="pill">Public anchor</span> <span class="small muted">(Grand View Research; IMARC; Fortune Business Insights; TowardsHealthcare)</span></b><div>Public range for context: <u>$60–75B</u> (2024 base); <u>~6–8% CAGR</u> to 2032–2034.</div><div class="small">Sourced from public summaries; used as a deck‑safe anchor range. Our internal Statista‑licensed anchor ($74.7B / 7.5%) sits at the top of this band.</div><div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div><div class="ref"><b>Statista (2024) – Global Cardiovascular Devices <span class="pill">Internal</span></b><div>Key figures used internally: <u>$74.7B</u> 2024 baseline; <u>~7.5%</u> CAGR to 2035.</div><div class="small">Use for internal modeling only; in external materials cite the public range above.</div><div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div><div class="ref"><b>BCC Research (HLC/MDS series) – Pediatric subset <span class="pill">Internal</span></b><div>Working assumption (internal): Pediatric cardiac devices ≈ <u>~4%</u> of CV devices (~<u>$3.0B</u> in 2024); CAGR <u>~8.5%</u>; pediatric PPV share ≈ <u>~10%</u>.</div><div class="small">No public breakout available from BCC pages; treat as Osprey assumption derived from licensed content and epi mapping.</div><div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div><div class="ref"><b>Transcatheter Pulmonic Valves (TPV) – Category guardrails <span class="pill">Public anchor</span> <span class="small muted">(Grand View Research; Expert Market Research; MetaTech Insights)</span></b><div>Directional band: <u>~$70–100M</u> (2023–2024) with <u>~6–8% CAGR</u> toward early–mid 2030s; scope varies by source.</div><div class="small">Use as public guardrails for the category; does not equal pediatric PPV subset.</div><div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div><div class="ref"><b>Pediatric PPV devices – Internal model <span class="pill">Internal</span></b><div>Model anchor: ≈ <u>$300M</u> (2024) → <u>$677M</u> (2035); CAGR <u>~8.6%</u>.</div><div class="small">No exact public match; show build‑up (volumes × ASP × mix) in appendix; cross‑check against TPV guardrails.</div><div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div><div class="ref"><b>U.S. Pediatric Pulmonary Valve – Top‑Down Sizing <span class="pill">Internal</span></b><div>U.S. TAM <u>$125–140M</u> (2025); ≈ <u>3,800</u> annual interventions; <u>5–8%</u> CAGR → <u>$180–200M</u> by 2030.</div><div class="small">Label “Osprey model (internal)”; grounded in CHD/RVOT epidemiology and center‑level volumes.</div><div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div><div class="ref"><b>Pediatric PPV Canvas (Top‑Down vs Bottom‑Up) <span class="pill">Internal</span></b><div>2025 realized revenue ≈ <u>$65–70M</u>; strategic TAM ≈ <u>$133M</u> (3,800 × $35k ASP).</div><div class="small">Maintain in appendix with ASP ±20% sensitivity and surgical/TPV mix toggles.</div><div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div>
</div>
</section>
<!-- Epidemiology & Burden -->
<section aria-labelledby="h-epi" class="section" id="epi">
<div class="card">
<h3 id="h-epi">Epidemiology &amp; Burden</h3>
<div class="ref" data-tags="#Epidemiology #Baseline">
<b>Hoffman JIE, Kaplan S. JACC (2002).</b><div>Key figures used: CHD incidence baseline widely cited for modeling prevalence.</div><div class="small">Secondary: Osprey Intel research and analysis – epidemiology worksheet.</div>
<div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div>
<div class="ref" data-tags="#Epidemiology #Global">
<b>van der Linde D, et al. JACC (2011).</b><div>Key figures used: Global birth prevalence long‑run trend.</div><div class="small">Secondary: Osprey Intel research and analysis – global→U.S. scaling.</div>
<div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div>
<div class="ref" data-tags="#Epidemiology #MetaAnalysis">
<b>Liu Y, et al. Int J Epidemiol (2019).</b><div>Key figures used: Global birth prevalence 1970–2017 meta‑analysis; defect‑level prevalence.</div><div class="small">Secondary: “CHD vs Pulmonary Valve Disease” data explanation.</div>
<div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div>
<div class="ref" data-tags="#Epidemiology #US">
<b>Mai CT, et al. Birth Defects Res (2019).</b><div>Key figures used: U.S. defect‑specific prevalence; used to allocate RVOT cohort (~16% of CHD).</div><div class="small">Secondary: Pediatric CHD Sources Packet – cohort mapping.</div>
<div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div>
<div class="ref" data-tags="#Epidemiology #Mortality">
<b>Gilboa SM, et al. Circulation (2010).</b><div>Key figures used: U.S. CHD mortality trend; informs lifetime cohort curve.</div><div class="small">Secondary: Osprey Intel research and analysis.</div>
<div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div>
<div class="ref" data-tags="#HEOR #Burden">
<b>Additional Ventures (HEOR, 2024).</b><div>Key figures used: Lifetime cCHD cost ≈ <u>$2.2M</u> per patient; ≈ <u>$650k</u> in first 5 years.</div><div class="small">Secondary: IC memo – burden of illness slide.</div>
<div class="ref-actions"><button class="btn small copy">Copy key figures</button></div></div>
</div>
</section>
<!-- Standard of Care & Technologies -->
<section aria-labelledby="h-soc" class="section" id="soc">
<div class="card">
<h3 id="h-soc">Standard of Care &amp; Technologies</h3>
<div class="ref" data-tags="#SoC #Regulatory #Medtronic">
<b>Medtronic Melody / Harmony – FDA PMA Summaries &amp; Labeling.</b><div>Key details used: Fixed‑size tissue TPVs; indication constraints by anatomy; durability outcomes across follow‑up.</div><div class="small">Secondary: Competitive Landscape – Autus vs. Medtronic.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#Innovation #Growth">
<b>Science Translational Medicine (2020) – Growth‑Accommodating Valve Prototype.</b><div>Key details used: Serial expansion concept; maintaining leaflet performance across sizes.</div><div class="small">Secondary: Autus engineering notes.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#Regulatory #Stent">
<b>Renata Minima™ Stent – FDA Approval &amp; GROWTH Pivotal.</b><div>Key details used: First FDA‑approved pediatric growth‑accommodating stent; expansion profile and early outcomes.</div><div class="small">Secondary: Osprey Intel research and analysis.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#Regenerative #EU">
<b>Xeltis Restorative Valved Conduit – EU Clinical Disclosures.</b><div>Key details used: Endogenous tissue restoration; EU pivotal pathway.</div><div class="small">Secondary: Market landscape notes.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
</div>
</section>
<!-- Regulatory & Funding -->
<section aria-labelledby="h-reg" class="section" id="reg">
<div class="card">
<h3 id="h-reg">Regulatory &amp; Funding Pathways</h3>
<div class="ref" data-tags="#Regulatory #FDA #Pediatrics">
<b>FDA – PMA / HDE / Breakthrough Device programs.</b><div>Key details used: PMA Class III standard; HDE &lt;8,000/year, probable benefit, pediatric profit allowance; Breakthrough interactions across IDE/PMA.</div><div class="small">Secondary: Regulatory Overview (updated) – submission checklist.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#Funding #NIH #PDC">
<b>NIH/NHLBI, Pediatric Device Consortia (UCSF‑Stanford PDC, CTIP, APDI, SWPDC).</b><div>Key details used: non‑dilutive funding &amp; technical guidance for pediatric devices.</div><div class="small">Secondary: Investor Brief – funding strategy.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
</div>
</section>
<!-- Company & Pipeline -->
<section aria-labelledby="h-company" class="section" id="company">
<div class="card">
<h3 id="h-company">Company &amp; Pipeline</h3>
<div class="ref" data-tags="#Pipeline #ClinicalTrials">
<b>ClinicalTrials.gov – NCT05006404 (Autus Valve Pivotal).</b><div>Key details used: Pediatric cohort eligibility; primary endpoints; long‑term follow‑up (up to 10 years).</div><div class="small">Secondary: Autus trial dashboard.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#IP #Breakthrough">
<b>Autus Valve – U.S. Patents &amp; Breakthrough Designation (2023).</b><div>Key details used: Size‑adjustable frame; leaflet performance across expansions; Breakthrough status for pediatric indication.</div><div class="small">Secondary: Autus company overview dashboard.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#Pipeline #Regenerative">
<b>PECA Labs – MASA Conduit (IDE EFS); PolyVascular, Annoviant.</b><div>Key details used: Growth‑accommodating conduit; polymer and regenerative alternatives in early clinical stages.</div><div class="small">Secondary: Competitive landscape notes.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
</div>
</section>
<!-- M&A Comps & Valuation -->
<section aria-labelledby="h-comps" class="section" id="comps">
<div class="card">
<h3 id="h-comps">M&amp;A Comps &amp; Valuation</h3>
<div class="ref" data-tags="#Comps #Valuation">
<b>Edwards–CardiAQ (2015).</b><div>Key details used: $320M transaction; novel valve tech benchmark.</div><div class="small">Secondary: IC memo – comps table.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#Comps #Valuation">
<b>Boston Scientific–Apama (2017).</b><div>Key details used: $300M transaction; structural heart innovation.</div><div class="small">Secondary: IC memo – comps table.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#Comps #Scale">
<b>Abbott–Cardiovascular Systems (2023).</b><div>Key details used: $851M transaction; interventional device scale.</div><div class="small">Secondary: Investor Brief – comps section.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#Comps #Milestones">
<b>Johnson &amp; Johnson–V‑Wave (2024).</b><div>Key details used: $600M upfront (+ milestones; up to $1.1B); cardiology exit precedent.</div><div class="small">Secondary: Investor Brief – comps section.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
</div>
</section>
<!-- Guidelines & Registries -->
<section aria-labelledby="h-guidelines" class="section" id="guidelines">
<div class="card">
<h3 id="h-guidelines">Guidelines &amp; Registries</h3>
<div class="ref" data-tags="#Guidelines #ACHD">
<b>2018 AHA/ACC Adult Congenital Heart Disease Guideline.</b><div>Key details used: Adult congenital follow‑up expectations and intervention triggers; informs lifetime management.</div><div class="small">Secondary: Standard of care notes.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#Guidelines #ESC">
<b>2020 ESC Adult Congenital Heart Disease Guideline.</b><div>Key details used: European guidance parallels; registry follow‑up expectations.</div><div class="small">Secondary: Osprey Intel research and analysis.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#Registries #STS">
<b>STS Congenital Heart Surgery Database – Annual Reports.</b><div>Key details used: Center volumes and outcomes trend overlays for bottom‑up sizing.</div><div class="small">Secondary: Market models – bottom‑up worksheet.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
</div>
</section>
<!-- Patents & IP -->
<section aria-labelledby="h-ip" class="section" id="ip">
<div class="card">
<h3 id="h-ip">Patents &amp; IP</h3>
<div class="ref" data-tags="#IP #Autus">
<b>US 11,969,342 B2 – Growth‑Accommodating Prosthetic Heart Valve.</b><div>Key details used: Expansion range and leaflet performance limits.</div><div class="small">Secondary: Autus patent analysis notes.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#IP #Pediatrics">
<b>US 10,966,826 B2 – Pediatric Heart Valve Technologies.</b><div>Key details used: Valve structure and pediatric‑specific features.</div><div class="small">Secondary: Autus patent analysis notes.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
<div class="ref" data-tags="#IP #Autus">
<b>US 12,004,948 B2 – Related Autus Valve IP.</b><div>Key details used: Additional claims supporting growth accommodation.</div><div class="small">Secondary: Autus patent analysis notes.</div>
<div class="ref-actions"><button class="btn small copy">Copy key details</button></div></div>
</div>
</section>
<!-- Internal Osprey Materials -->
<section aria-labelledby="h-internal" class="section" id="internal">
<div class="card">
<h3 id="h-internal">Internal Osprey Materials</h3>
<div class="ref" data-tags="#Internal #Models">
<b>Osprey Intel research and analysis.</b><div>Key details used: Consolidated models (top‑down &amp; bottom‑up), epidemiology mapping, ASP &amp; volume assumptions, HEOR synthesis.</div></div>
<div class="ref" data-tags="#Internal #Valuation">
<b>Investment Committee Memo – Pediatric RVOT Lesion Management.</b><div>Key details used: Exit scenarios ($150–400M), $250M midpoint, valuation framework.</div></div>
<div class="ref" data-tags="#Internal #Finance">
<b>Pre‑Money Valuation (VC Method) &amp; Pro‑Forma Cap Table.</b><div>Key details used: $30M pre / $45M post; 33.3% investor stake; 15% ESOP; IRR/MOIC math.</div></div>
<div class="ref" data-tags="#Internal #Competition">
<b>Pediatric Pulmonary Valve Canvas &amp; Competitive Landscape Notes.</b><div>Key details used: Autus vs. Medtronic positioning; pipeline company profiles; risk/mitigant mapping.</div></div>
</div>
</section>
<section class="section"><div class="muted" id="labeling-key">Labeling key: “Public anchor” = deck‑safe citation range from public sources; “Internal” = Osprey model or licensed/proprietary figures (do not attribute publicly).</div>
<div class="muted">© 2025 Osprey Intel LLC • Expanded references with annotated primary-source figures. Use <span class="kbd">Ctrl/⌘+F</span> or the search box (<span class="kbd">/</span>) to find entries.</div>
</section>
</main>
</div>
<script>
  // Active section highlighting
  function setActiveNav() {
    const hash = location.hash || '#market';
    document.querySelectorAll('.nav-link[href^="#"]').forEach(a => {
      a.setAttribute('aria-current', a.getAttribute('href') === hash ? 'true' : 'false');
    });
  }
  window.addEventListener('hashchange', setActiveNav);
  window.addEventListener('load', setActiveNav);

  // Search + filter by text or #tags
  const q = document.getElementById('q');
  const clearBtn = document.getElementById('clear');
  const refs = Array.from(document.querySelectorAll('.ref'));
  const count = document.getElementById('resultCount');

  function applyFilter() {
    const term = (q.value || '').trim().toLowerCase();
    let visible = 0;
    refs.forEach(ref => {
      const text = ref.textContent.toLowerCase();
      const tags = (ref.getAttribute('data-tags')||'').toLowerCase();
      const match = term === '' || text.includes(term) || tags.includes(term);
      ref.style.display = match ? '' : 'none';
      if (match) visible++;
    });
    count.textContent = visible + ' match' + (visible === 1 ? '' : 'es');
  }

  q?.addEventListener('input', applyFilter);
  clearBtn?.addEventListener('click', () => { q.value=''; applyFilter(); q.focus(); });
  window.addEventListener('load', applyFilter);

  // Keyboard shortcut: '/' focuses search
  window.addEventListener('keydown', (e) => {
    if (e.key === '/' && document.activeElement !== q) {
      e.preventDefault(); q.focus();
    }
  });

  // Copy key figures/details from each ref (first non-small div)
  function copyText(text){
    navigator.clipboard.writeText(text).then(()=>{
      // Optional: temporary status text
    }).catch(()=>{});
  }
  document.querySelectorAll('.ref .copy').forEach(btn => {
    btn.addEventListener('click', () => {
      const ref = btn.closest('.ref');
      // Prefer the first child div that is not .small
      const target = Array.from(ref.querySelectorAll('div')).find(d => !d.classList.contains('small'));
      copyText(target ? target.innerText : ref.innerText);
      btn.textContent = 'Copied';
      setTimeout(()=> btn.textContent = 'Copy key figures', 1200);
    });
  });
</script>
<!-- Optional JSON-LD stub to enable structured data; replace placeholders with real identifiers when available. -->
<script type="application/ld+json">{
  "@context": "https://schema.org",
  "@type": "CollectionPage",
  "name": "Works Cited / References – Expanded & Annotated",
  "about": [{"@type":"MedicalDevice","name":"Pediatric pulmonary valve"}],
  "hasPart": [
    {"@type":"CreativeWork","name":"Global Cardiovascular Devices","publisher":"Statista","datePublished":"2024"},
    {"@type":"ScholarlyArticle","name":"CHD incidence baseline","author":"Hoffman JIE; Kaplan S","datePublished":"2002","isPartOf":{"name":"JACC"}}
  ]
}</script>
</body>
</html>